Nivolumab/relatlimab
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Pharmacovigilance and Adverse Drug Reactions
T-cell and B-cell Immunology
Publication details
- Journal / source
- Reactions Weekly
- Volume
- 2092
- Issue
- 1
- Pages
- 73–73
- Publication date
- 10 January 2026
- Language
- EN